GAS6 and prostate carcinoma: Additionally, growth arrest specific-6 (GAS6), a ligand secreted by osteoblasts in the bone marrow environment, contributes to the dormancy of prostate cancer-derived DTCs and inhibits the proliferation of hematopoietic progenitors [172, 173].